期刊文献+

支气管哮喘患者呼出气冷凝液和诱导痰中炎性指标检测的临床意义 被引量:1

The clinical significance of non/nvasive inflammatory markers in exhaled breath condensate and induced sputum in persistent asthmatic patients
原文传递
导出
摘要 目的通过测定支气管哮喘(以下简称哮喘)患者呼出气冷凝液(EBC)和诱导痰中炎性指标的浓度,分析其与临床指标的关系,探讨炎性指标用于病情和疗效评估的价值。方法选四川大学华西医院呼吸内科门诊接受吸入糖皮质激素联合长效β2受体激动剂治疗的中重度慢性持续期哮喘患者,记录治疗前和治疗1个月后哮喘症状积分,测定第1秒钟用力呼气容积(FEV1)占预计值百分比,采集诱导痰和EBC标本,测定标本中过氧化氢(H2O2)、硝酸盐/亚硝酸盐(N03-/NO2-)和半胱氨酰白三烯E4(LTE4)浓度。结果共有25例中重度哮喘患者按研究方案完成治疗和随访。哮喘患者经联合治疗1个月后临床症状积分和FEV1占预计值百分比明显改善(P〈0.01);EBC和诱导痰中H2O2、N03-/NO2-和LTE4浓度均降低,但仍高于健康对照者;H2O2和NO3-/NO2-的下降比LTE4明显;哮喘患者EBC中的H2O2和NO3-/NO2-浓度与FEV1呈负相关(P〈0.01),与症状积分呈正相关(P〈0.01),LTE。与症状积分和FEV1均无相关性。诱导痰中H2O2浓度与FEV1占预计值百分比呈负相关(P〈0.01),与症状积分呈正相关(P〈0.01);NO3-/NO2-浓度与FEV1占预计值百分比呈负相关(P〈0.01),与症状积分无相关性;LTE4浓度与症状积分和FEV1占预计值百分比均无相关性。治疗后FEV1占预计值百分比增高程度与EBC和诱导痰中H2O2、NO3-/NO2-浓度降低水平呈正相关(P〈0.01)。诱导痰和EBC对应的炎性指标之间有相关性(P值均小于0.01)。EBC和诱导痰中H2O2浓度与NO3-/NO2-浓度呈正相关(P〈0.01),与LTE4之间无相关性。结论中重度哮喘患者联合治疗后在临床症状和肺功能改善的同时,气道炎症显著减轻。EBC的安全性和可重复性优于诱导痰,H202和NO3-/NO2-的敏感性优于LTE4。 Objective To assess the clinical significance of three different noninvasive airway inflammatory indices in induced sputum and exhaled breath condensate (EBC) from persistent asthmatic patients. Methods Moderate and severe asthmatic patients were prescribed inhaled corticosteroids combined with long-acting [32 agonists for a month. The symptom scores and percentage of predicted value of forced expiratory volume in one second ( FEVI ) ( FEV1% pred) were measured while the concentrations of H2O2, NO3-/NO2- , and cysteinyl-leukotriene E4 (LTE4 ) in induced sputum and EBC were detected before and after therapy. Results A total of twenty-five subjects with moderate and severe asthma were enrolled. By combined therapy for one month the asthma symptoms relieved and FEV1% pred improved significantly (P〈0.01). The concentrations of H2O2, NO3-/NO2- and LTE4 in induced sputum and EBC declined significantly(P 〈0. 01 ) although the concentrations were still higher than those at normal baseline. More marked reduction of H2O2 and NO3-/NO2 compared to LTE4 was observed. It was revealed that the concentrations of H2O2 and NO3-/NO2- but not of LTE4 in EBC were negatively correlated with FEV1% pred (P 〈 0. 01 ) and positively with symptom scores. Such correlations were also found in H2O2 in induced sputum with FEV1% pred and symptom scores as well as NO3/NO2 in induced sputum with FEV1 % pred. The improvement of FEV1% pred after treatment was positively correlated with the reduction of n2O2 and NO3-/NO2- both in induced sputum and EBC. Correlation analysis also demonstrated three inflammatory indices were equivalent in induced sputum and EBC ( correlation coefficient of H2 O2, NO;/NO2 and LTE4, 0. 759,0. 826 and 0. 653, respectively. P 〈 0. 01 ). Conclusions ( 1 ) Combined therapy with inhaled corticosteroid plus long-acting [32 agonist significantly improves the clinical symptoms and lung function of patients with moderate and severe asthma companied with marked suppression of airway inflammation. (2) Both of EBC and induced sputum sampling are valuable noninvasive procedures for detecting asthma airway inflammation, however, EBC technique is superior in safety and reproducibility. (3) H2O2 and NO3-/NO2- seem to be more sensitive indices in diagnosis and monitoring asthma compared to LTE4.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第4期299-303,共5页 Chinese Journal of Internal Medicine
关键词 哮喘 呼出气冷凝液 诱导痰 过氧化氢 白三烯E4 一氧化氮 Asthma Exhaled breath condensate Induced sputum Hydrogen peroxide Leukotriene E4 Nitric oxide
  • 相关文献

参考文献20

  • 1Bousquet J, Jeffery PK, Busse WW, et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med,2000,151 : 1720-1745.
  • 2中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3565
  • 3李凡,蔡映云,王蓓玲,唐世和.5分制成人哮喘生存质量评分表的检验[J].现代康复,2001,5(12S):7-9. 被引量:101
  • 4Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax, 1992,47:25-29.
  • 5Kharitonov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers,2002,7:1-32.
  • 6Antczak A, Nowak D, Shariati B, et al. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J, 1997, 10: 1235- 1241.
  • 7Jobsis Q, Raatgeep HC, Hermans PW, et al. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J, 1997,10:519-521.
  • 8Antczak A, Kurmanowska Z, Kasielski M, et al. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med ,2000,94:416-421.
  • 9Kharitonov SA, Yates D, Robbias RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet, 1994,343 : 133- 135.
  • 10Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet, 1994,343 : 146-147.

二级参考文献22

  • 1Kanazawa H,Shoji S,Yamada M,et al.Increased levels of nitric oxide derivatives in induced sputum in patients with asthma.J Allergy Clin Immunol,1997,99:624-629.
  • 2WHO/NHLBI Workshop Report.Global initiative for asthma management and prevention:pocket guide for asthma management and prevention in children.Maryland:National Institute of Health,National Heart,Lung,and Blood Institute,2002.6-9.
  • 3Pin I,Gibson PG,Kolendowicz R,et al.Use of induced sputum cell counts to investigate airway inflammation in asthma.Thorax,1992,47:25-29.
  • 4袁玉如.呼吸功能测定.见:王曾礼,冯玉麟,主编.呼吸病诊疗手册.北京:人民卫生出版社,2000.101-102.
  • 5Prosperini G,Rajakulasingam K,Cacciola RR,et al.Changes in sputum counts and airway hyperresponsiveness after budesonide:monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation.J Allergy Clin Immunol,2002,110:855-861.
  • 6Fahy JV,Liu J,Wong H,et al.Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects.Am Rev Respir Dis,1993,147:1126-1131.
  • 7Foresi A,Mastropasque B,Chetta A,et al.Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.Chest,2005,127:117-124.
  • 8Bateman ED,Boushey HA,Bousquet J,et al.Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma ControL study.Am J Respir Crit Care Med,2004,170:836-844.
  • 9Mahut B,Delacourt C,Zerah-Lancner F,et al.Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma.Chest,2004,125:1012-1018.
  • 10Kharitonov SA,Donnelly LE,Montuschi P,et al.Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.Thorax,2002,57:889-896.

共引文献3659

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部